The components of the Company’s net deferred
tax assets as of March 31, 2025, and December 31, 2024, were as follows (in thousands):
| |
March 31, 2025 | | |
December 31, 2024 | |
| |
(In thousands) | |
Deferred tax assets: | |
| | |
| |
Net Operating loss carry-forward | |
$ | 476 | | |
$ | 1,439 | |
Add back: | |
| | | |
| | |
Stock-based compensation | |
| (10 | ) | |
| (30 | ) |
Depreciation and amortization | |
| 3 | | |
| (249 | ) |
Impairment expense | |
| - | | |
| — | |
Bad debt | |
| - | | |
| (48 | ) |
Fair value of warrant | |
| - | | |
| (43 | ) |
Gain on revaluation | |
| | | |
| — | |
Other income | |
| 31 | | |
| - | |
Total deferred tax asset | |
| 500 | | |
| 1,069 | |
Less: valuation allowance | |
$ | (500 | ) | |
$ | (1,069 | ) |
Deferred tax asset. net of valuation allowance | |
| — | | |
| — | |
Deferred tax liabilities | |
| — | | |
| — | |
Net deferred tax asset | |
| — | | |
| — | |
|